LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹117 Cr | ₹96 Cr | ₹111 Cr | ₹95 Cr | ₹80 Cr |
What is the latest Total Current Liabilities ratio of LINCOLN PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹117 Cr |
Mar2023 | ₹96 Cr |
Mar2022 | ₹111 Cr |
Mar2021 | ₹95 Cr |
Mar2020 | ₹80 Cr |
How is Total Current Liabilities of LINCOLN PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹117 Cr | 22.29 | |
Mar2023 | ₹96 Cr | -13.27 | |
Mar2022 | ₹111 Cr | 16.80 | |
Mar2021 | ₹95 Cr | 18.01 | |
Mar2020 | ₹80 Cr | - |
Compare Total Current Liabilities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,093.4 Cr | -0.2% | -4.5% | -6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.2% |
-4.5% |
-6.6% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses